JP2016010330A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016010330A5 JP2016010330A5 JP2014132622A JP2014132622A JP2016010330A5 JP 2016010330 A5 JP2016010330 A5 JP 2016010330A5 JP 2014132622 A JP2014132622 A JP 2014132622A JP 2014132622 A JP2014132622 A JP 2014132622A JP 2016010330 A5 JP2016010330 A5 JP 2016010330A5
- Authority
- JP
- Japan
- Prior art keywords
- ips cells
- foreign
- cells
- gene
- episomal vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cells Anatomy 0.000 claims 28
- 210000002242 Embryoid Bodies Anatomy 0.000 claims 9
- 239000003814 drug Substances 0.000 claims 8
- 229940079593 drugs Drugs 0.000 claims 8
- 239000003550 marker Substances 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Destomysin Chemical compound OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 claims 4
- 229940097277 Hygromycin B Drugs 0.000 claims 4
- 210000004263 Induced Pluripotent Stem Cells Anatomy 0.000 claims 4
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 4
- -1 cationic lipid Chemical class 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 239000012096 transfection reagent Substances 0.000 claims 4
- 230000003068 static Effects 0.000 claims 3
- 230000000875 corresponding Effects 0.000 claims 2
- 108091005938 enhanced green fluorescent protein Proteins 0.000 claims 2
- 102000003995 transcription factors Human genes 0.000 claims 2
- 108090000464 transcription factors Proteins 0.000 claims 2
- 102100006141 FOXA2 Human genes 0.000 claims 1
- 101700049079 FOXA2 Proteins 0.000 claims 1
- 102100012697 GATA4 Human genes 0.000 claims 1
- 101700002184 GATA4 Proteins 0.000 claims 1
- 102100016999 HHEX Human genes 0.000 claims 1
- 101700047478 HHEX Proteins 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 230000004069 differentiation Effects 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 230000002062 proliferating Effects 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
Claims (11)
1)エピソーマルベクターを用いて、iPS細胞に外来遺伝子を非リポソーム型カチオン性脂質トランスフェクション試薬を用いてトランスフェクションする工程、
2)外来遺伝子がトランスフェクションされたiPS細胞を、薬剤選択マーカー及び/又はレポーター遺伝子を用いて選別する工程、及び
3)選別されたiPS細胞を、非静的な培養方法で培養し、胚様体まで増殖させる工程
を含む方法。 A method of expressing a plurality of foreign genes in an embryoid body composed of human induced pluripotent stem cells (iPS cells),
1) Transfecting an iPS cell with a foreign gene using a non-liposomal cationic lipid transfection reagent using an episomal vector,
2) a step of selecting iPS cells transfected with a foreign gene using a drug selection marker and / or a reporter gene, and 3) culturing the selected iPS cells by a non-static culture method, A method comprising the step of growing to the body.
1)エピソーマルベクターを用いて、iPS細胞に外来遺伝子を非リポソーム型カチオン性脂質トランスフェクション試薬を用いてトランスフェクションする工程、
2)外来遺伝子がトランスフェクションされたiPS細胞を、薬剤選択マーカー及び/又はレポーター遺伝子を用いて選別する工程、及び
3)選別されたiPS細胞を、非静的な培養方法で培養し、胚様体まで増殖させる工程
を含む方法で製造された胚様体。 An embryoid body into which a foreign gene consisting of human induced pluripotent stem cells (iPS cells) has been introduced,
1) Transfecting an iPS cell with a foreign gene using a non-liposomal cationic lipid transfection reagent using an episomal vector,
2) selecting iPS cells transfected with a foreign gene using a drug selection marker and / or a reporter gene; and
3) A step of culturing selected iPS cells by a non-static culture method and allowing them to grow to embryoid bodies
An embryoid body produced by a method comprising:
1)エピソーマルベクターに、
(i) 外来遺伝子、
(ii) G418(登録商標)又はハイグロマイシンBに対する薬剤選択マーカー、及び、
(iii) EGFPをコードする核酸配列(配列番号7)又はCherryPicker(登録商標)をコードする核酸配列(配列番号8)を有するレポーター遺伝子の(i)ないし(iii)を組み合わせて組み込んだ複数の種類のエピソーマルベクター構築物を作製する工程、
2)複数のエピソーマルベクター構築物を非リポソーム型カチオン性脂質トランスフェクション試薬を用いてiPS細胞にトランスフェクションすることにより、複数の外来遺伝子をiPS細胞にトランスフェクションする工程、
3) (i)ないし(iii)の組み合わせに対応して、
G418及び/又はハイグロマイシンBの添加により薬剤選択マーカーを用いて、及び/又は、
緑色及び/又は赤色の蛍光を指標としてレポーター遺伝子を用いて、
前記複数の外来遺伝子が導入されたiPS細胞を選別する工程、並びに、
4)選別されたiPS細胞を、1.6から160×103個/mLの細胞濃度で、回転速度2.5から9.9rpmの回転培養法で培養し、胚様体まで増殖させる工程
を含む方法。 A method of expressing a plurality of foreign genes in an embryoid body composed of human induced pluripotent stem cells (iPS cells),
1) In episomal vector,
(i) foreign genes,
(ii) a drug selection marker for G418® or hygromycin B, and
(iii) Multiple types of reporter genes (i) to (iii) incorporated in combination with a nucleic acid sequence encoding EGFP (SEQ ID NO: 7) or a nucleic acid sequence encoding Cherry Picker (registered trademark) (SEQ ID NO: 8) Producing an episomal vector construct of
2) transfecting a plurality of foreign genes into iPS cells by transfecting a plurality of episomal vector constructs into iPS cells using a non-liposomal cationic lipid transfection reagent;
3) Corresponding to the combination of (i) to (iii),
Using drug selection markers by the addition of G418 and / or hygromycin B, and / or
Using a reporter gene with green and / or red fluorescence as an indicator,
Selecting iPS cells into which the plurality of foreign genes have been introduced, and
4) A step of culturing the selected iPS cells at a cell concentration of 1.6 to 160 × 10 3 cells / mL by a rotary culture method at a rotational speed of 2.5 to 9.9 rpm, and proliferating to an embryoid body. Including methods.
1)エピソーマルベクターに、1) In episomal vector,
(i) 外来遺伝子、(i) foreign genes,
(ii) G418(登録商標)又はハイグロマイシンBに対する薬剤選択マーカー、及び、(ii) a drug selection marker for G418® or hygromycin B, and
(iii) EGFPをコードする核酸配列(配列番号7)又はCherryPicker(登録商標)をコードする核酸配列(配列番号8)を有するレポーター遺伝子の(i)ないし(iii)を組み合わせて組み込んだ複数の種類のエピソーマルベクター構築物を作製する工程、(iii) Multiple types of reporter genes (i) to (iii) incorporated in combination with a nucleic acid sequence encoding EGFP (SEQ ID NO: 7) or a nucleic acid sequence encoding Cherry Picker (registered trademark) (SEQ ID NO: 8) Producing an episomal vector construct of
2)複数のエピソーマルベクター構築物を非リポソーム型カチオン性脂質トランスフェクション試薬を用いてiPS細胞にトランスフェクションすることにより、複数の外来遺伝子をiPS細胞にトランスフェクションする工程、2) transfecting a plurality of foreign genes into iPS cells by transfecting a plurality of episomal vector constructs into iPS cells using a non-liposomal cationic lipid transfection reagent;
3) (i)ないし(iii)の組み合わせに対応して、3) Corresponding to the combination of (i) to (iii),
G418及び/又はハイグロマイシンBの添加により薬剤選択マーカーを用いて、及び/又は、Using drug selection markers by the addition of G418 and / or hygromycin B, and / or
緑色及び/又は赤色の蛍光を指標としてレポーター遺伝子を用いて、Using a reporter gene with green and / or red fluorescence as an indicator,
前記複数の外来遺伝子が導入されたiPS細胞を選別する工程、並びに、Selecting iPS cells into which the plurality of foreign genes have been introduced, and
4)選別されたiPS細胞を、1.6から160×104) Select iPS cells from 1.6 to 160 × 10 6 33 個/mLの細胞濃度で、回転速度2.5から9.9rpmの回転培養法で培養し、胚様体まで増殖させる工程A step of cultivating the cells to the embryoid body by culturing by a rotational culture method at a cell rotation rate of 2.5 to 9.9 rpm at a cell concentration of 1 cell / mL
を含む方法で製造された胚様体。An embryoid body produced by a method comprising:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014132622A JP6469371B2 (en) | 2014-06-27 | 2014-06-27 | A method for expressing a plurality of foreign genes in an embryoid body composed of induced pluripotent stem cells (iPS cells) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014132622A JP6469371B2 (en) | 2014-06-27 | 2014-06-27 | A method for expressing a plurality of foreign genes in an embryoid body composed of induced pluripotent stem cells (iPS cells) |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2016010330A JP2016010330A (en) | 2016-01-21 |
JP2016010330A5 true JP2016010330A5 (en) | 2017-08-10 |
JP6469371B2 JP6469371B2 (en) | 2019-02-13 |
Family
ID=55227519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014132622A Active JP6469371B2 (en) | 2014-06-27 | 2014-06-27 | A method for expressing a plurality of foreign genes in an embryoid body composed of induced pluripotent stem cells (iPS cells) |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6469371B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190141218A (en) * | 2017-04-26 | 2019-12-23 | 메모리얼 슬로안 케터링 캔서 센터 | Cryopreservation Cells Ready for Use |
CN107164527B (en) * | 2017-06-29 | 2018-04-20 | 杭州观梓健康科技有限公司 | It is a kind of to screen the method for participating in multipotential stem cell vitro directed differentiation regulatory factor |
CN111139218A (en) * | 2020-01-16 | 2020-05-12 | 协和干细胞基因工程有限公司 | Method for rapidly and efficiently preparing embryoid body by inducing pluripotent stem cell or embryonic stem cell |
-
2014
- 2014-06-27 JP JP2014132622A patent/JP6469371B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104178461B (en) | CAS9-carrying recombinant adenovirus and application thereof | |
JP7154525B2 (en) | Cell microcompartments and methods for their preparation | |
CN107922944A (en) | Engineered CRISPR CAS9 compositions and application method | |
JP2019520844A5 (en) | ||
Tanaka et al. | Ultrastructure and membrane traffic during cell division in the marine pennate diatom Phaeodactylum tricornutum | |
JP2014533491A5 (en) | ||
JP2018526992A5 (en) | ||
CN109689865A (en) | BCL11A homing endonuclease variants, composition and application method | |
CN110300803A (en) | Improve the method in cellular genome with source orientation reparation (HDR) efficiency | |
LeBlanc et al. | RNA trafficking in parasitic plant systems | |
EP4249036A3 (en) | Methods and products for nucleic acid production and delivery | |
Cherbas et al. | Cell lines | |
Sabatino et al. | Establishment of genetic transformation in the sexually reproducing diatoms Pseudo-nitzschia multistriata and Pseudo-nitzschia arenysensis and inheritance of the transgene | |
CN102703424B (en) | A kind of method of genome of E.coli point mutation of recombined engineering mediation | |
NZ616646A (en) | Synthetic genes | |
CN108342362A (en) | A kind of stable cell lines MDCK and its construction method for expanding recombination hepatitis infectiosa canis virus CAV2 | |
JP2016010330A5 (en) | ||
US20170369878A1 (en) | Microrna combinations for anti-cancer therapeutics | |
JP2016027797A5 (en) | ||
JP2012143229A5 (en) | ||
JP2014516530A5 (en) | ||
CN104726500A (en) | Application of MicroRNA26b-3p inhibitor in preparation of human umbilical cord derived mesenchymal stem cell | |
KR101776368B1 (en) | mRNA nanoparticles and manufacturing method thereof | |
CN102628029B (en) | Thalassemia-induced multipotent stem cell as well as preparation method and application thereof | |
CN108239620B (en) | MDCK cell strain with IFN-beta 1 coding gene deletion and construction method and application thereof |